Stockscreener 앱 받기
2.235
1.11%
-0.025
전일 마감가:
$2.26
열려 있는:
$2.25
하루 거래량:
204.55K
Relative Volume:
0.16
시가총액:
$158.70M
수익:
$20.76M
순이익/손실:
$-132.49M
주가수익비율:
-0.8371
EPS:
-2.67
순현금흐름:
$-108.55M
1주 성능:
-1.54%
1개월 성능:
+59.64%
6개월 성능:
-38.43%
1년 성능:
-65.62%
1일 변동 폭
$2.19
$2.265
1주일 범위
$2.145
$2.44
52주 변동 폭
$1.085
$7.3573
C 4 Therapeutics Inc Stock (CCCC) Company Profile
명칭
C 4 Therapeutics Inc
전화
(617) 231-0700
주소
490 ARSENAL WAY, WATERTOWN
CCCC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CCCC
C 4 Therapeutics Inc
|
2.235 | 160.48M | 20.76M | -132.49M | -108.55M | -2.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.53 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.90 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.34 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
596.22 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
297.94 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
C 4 Therapeutics Inc Stock (CCCC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-11-18 | 개시 | Stephens | Equal-Weight |
| 2024-01-29 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2023-12-13 | 업그레이드 | Stifel | Hold → Buy |
| 2023-02-24 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2023-02-24 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2022-11-04 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-10-11 | 개시 | Morgan Stanley | Underweight |
| 2022-04-28 | 개시 | Credit Suisse | Underperform |
| 2022-04-11 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-03-10 | 개시 | JP Morgan | Overweight |
| 2022-02-11 | 재개 | BMO Capital Markets | Outperform |
| 2022-02-10 | 개시 | Wells Fargo | Equal Weight |
| 2021-11-23 | 개시 | BofA Securities | Buy |
| 2021-10-14 | 개시 | SVB Leerink | Mkt Perform |
| 2021-09-30 | 개시 | Stifel | Hold |
| 2021-06-04 | 개시 | H.C. Wainwright | Buy |
| 2021-03-31 | 개시 | BMO Capital Markets | Outperform |
| 2020-10-28 | 개시 | UBS | Buy |
| 2020-10-27 | 개시 | BMO Capital Markets | Outperform |
| 2020-10-27 | 개시 | Jefferies | Buy |
모두보기
C 4 Therapeutics Inc 주식(CCCC)의 최신 뉴스
Is C4 Therapeutics Inc. a growth stock or a value stockRecord-setting profit potential - jammulinksnews.com
What makes C4 Therapeutics Inc. stock price move sharplyMarket Forecast Review For 2025 - jammulinksnews.com
What are the latest earnings results for C4 Therapeutics Inc.Discover stocks with superior performance - jammulinksnews.com
Is it the right time to buy C4 Therapeutics Inc. stockInvest confidently with professional market insights - jammulinksnews.com
What are C4 Therapeutics Inc. company’s key revenue driversRapid-fire capital growth - jammulinksnews.com
Why is C4 Therapeutics Inc. stock attracting strong analyst attentionMaximize gains with data-driven trading alerts - jammulinksnews.com
When is C4 Therapeutics Inc. stock expected to show significant growthBuild wealth steadily with proven stock picks - jammulinksnews.com
Why C4 Therapeutics Inc. stock attracts strong analyst attentionFree Exclusive Stock Market Insights - beatles.ru
New Product Launches: Will They Boost C4 Therapeutics Inc. Stock in 2025Daily Breakout Picks - Metal.it
What analysts say about C4 Therapeutics Inc. stock outlookFree Predictions - Metal.it
What analysts say about C4 Therapeutics Inc. stockExceptional stock performance - PrintWeekIndia
Is C4 Therapeutics Inc. a good long term investmentExceptional financial outcomes - PrintWeekIndia
C4 Therapeutics Inc. Stock Analysis and ForecastMarket-crushing stock picks - PrintWeekIndia
What drives C4 Therapeutics Inc. stock priceMarket-beating performance - jammulinksnews.com
C4 Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights - ADVFN Brasil
C 4 Therapeutics Inc (CCCC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
C 4 Therapeutics Inc 주식 (CCCC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Boyle Scott N | Chief Business Officer |
Feb 14 '25 |
Sale |
3.15 |
490 |
1,544 |
110,842 |
0.58%
1.04%
자본화:
|
볼륨(24시간):